Amiko develops advanced sensor technologies and AI-enabled mobile health solutions to assist healthcare professionals and empower patients to achieve better outcomes.
Biotechnology company developing a unique oral device for delivery of biologics that would otherwise be injected.
CogniScent combines clinically validated testing with data-driven insights to support a timely diagnosis and self-management of neurodegenerative diseases, such as Parkinson’s and Alzheimer’s. CogniScent is a business angel investment by our managing director Jürgen Sanner.
Fertilly is committed to making a change in how fertility care is managed across Europe. As unique online platform Fertilly offers pre-medical advisory services and patient-centered, digital processes guiding through the individual fertility journey.
The digital health solution Kata® by Vision Health utilizes a combination of machine learning and augmented reality to enhance chronic pulmonary disease self-management as well as to bridge the communication and training gap between patients, physicians and providers.
OnDosis is developing a game changing drug delivery platform for personalized and connected dosing of medicines with the objective to improve treatment outcomes for a wide array of diseases and patients. Its proprietary technology delivers flexible and individualised dosing of oral medicines formulated as micro units such as granules and multiparticulates.
The first company worldwide that markets truly personalized nutritional supplements based on recurring, pain-free blood sampling at home.